PET Drug Manufacturers Must Establish Quality Control Units - GMP Draft Reg
Executive Summary
PET manufacturers must establish quality control units to oversee production operations, FDA's "Preliminary Draft Regulation on Current Good Manufacturing Practices for PET Drugs" states.
You may also be interested in...
PET Drugs Draft Rule Relaxes Proposed GMP Requirements After Comments
FDA's latest proposed rule on current good manufacturing practices for positron emission tomography products drops several requirements that had been included in previous iterations of the reg
PET Drugs Draft Rule Relaxes Proposed GMP Requirements After Comments
FDA's latest proposed rule on current good manufacturing practices for positron emission tomography products drops several requirements that had been included in previous iterations of the reg
PET O-15 Imaging Agent Literature Filing Is Inadequate; F-18, N-13 Okayed
Additional information is needed to support FDA approval for use of water O-15 injection imaging agent to measure cerebral blood flow in patients with cerebral vascular disorders in conjunction with positron emission tomography, FDA's Medical Imaging Drugs Advisory Committee concluded June 29.